Breaking News Instant updates and real-time market news.

HIMX

Himax

$8.58

-0.06 (-0.69%)

, TZA

Small Cap Bear 3x

$27.07

0.09 (0.33%)

08:45
10/07/16
10/07
08:45
10/07/16
08:45

Largest borrow rate increases among liquid names

Latest data shows the largest indicative borrow rate increases among liquid option names include: Himax Technologies (HIMX) 11.01% +1.47, Direxion Daily Small Cap Bear 3X Shares (TZA) 4.65% +0.46, P&G (PG) 0.78% +0.27, Gap (GPS) 1.06% +0.26, Novavax (NVAX) 11.44% +0.22, Euro ETF (FXE) 2.19% +0.19, Deutsche Bank (DB) 1.79% +0.17, Under Armour (UA) 2.12% +0.14, iShares Germany (EWG) 0.87% +0.13, and EWZ (EWZ) 0.47% +0.11.

HIMX

Himax

$8.58

-0.06 (-0.69%)

TZA

Small Cap Bear 3x

$27.07

0.09 (0.33%)

PG

Procter & Gamble

$89.22

0.37 (0.42%)

GPS

Gap

$22.78

0.25 (1.11%)

NVAX

Novavax

$1.88

-0.13 (-6.47%)

FXE

Euro Currency Trust

$108.48

-0.54 (-0.50%)

DB

Deutsche Bank

$13.53

-0.06 (-0.44%)

UA

Under Armour; also tag UAA

$37.82

-0.59 (-1.54%)

EWG

iShares MSCI Germany

$26.27

-0.12 (-0.45%)

EWZ

MSCI Brazil Index

$35.14

0.22 (0.63%)

  • 11

    Oct

  • 11

    Oct

  • 23

    Oct

  • 25

    Oct

  • 25

    Oct

  • 16

    Nov

HIMX Himax
$8.58

-0.06 (-0.69%)

09/26/16
NOMU
09/26/16
DOWNGRADE
NOMU
Neutral
Himax downgraded to Neutral from Buy at Nomura
09/28/16
ROTH
09/28/16
INITIATION
Target $10
ROTH
Buy
Himax initiated with a Buy at Roth Capital
Roth Capital analyst Suji Desilva initiated Himax with a Buy and a $10 price target. Desilva believes newer HIMX products can participate in growth of IoT device categories such as augmented reality and virtual reality head-mounted devices.
09/29/16
FBCO
09/29/16
NO CHANGE
FBCO
Outperform
Himax long-term story intact, says Credit Suisse
Credit Suisse analyst Jerry Su lowered Himax's LCOS/WLO shipment assumptions for Q4-1H 2017 on slower new platform adoption following supply chain checks. Su said the 2018 AR device ramp is on track and believes Himax's long-term story on consumer AR glass and 3D sensing for smartphone remains intact, since the capacity ramp up remains on schedule. The analyst said the potential launch of consumer AR glass and 3D sensing for smartphone should boost Himax's earnings in 2018 and reiterates his Outperform rating and $14 price target.
09/02/16
NOMU
09/02/16
NO CHANGE
Target $12
NOMU
Buy
Himax price target raised to $12 on better pricing at Nomura
Nomura analyst Donnie Teng noted that Himax has been able to raise its prices for its liquid crystal on silicon, or LCOS, and wafer level optics, or WLO, for a major augmented reality device recently, which he believes could help the company reach the higher end of its Q3 sales guidance. Teng raised his price target on Himax shares to $12 from $9.70, adding that the company plans to try to provide more cost effective LCOS and WLO products for a possible consumer AR device in 2018, which lead to higher demand. Nomura keeps a Buy rating on the stock.
TZA Small Cap Bear 3x
$27.07

0.09 (0.33%)

PG Procter & Gamble
$89.22

0.37 (0.42%)

07/22/16
STFL
07/22/16
NO CHANGE
STFL
Procter & Gamble price target raised to $92 from $85 at Stifel
Stifel expects Procter & Gamble's stock to be boosted by multiple expansion, driven by improving organic sales in fiscal 2017. The firm says that the company's margins should continue to expand. It believes that the stock's valuation is attractive, and it keeps a Buy rating on the shares.
08/26/16
JEFF
08/26/16
NO CHANGE
Target $75
JEFF
Hold
Jefferies cuts Edgewell Personal Care target citing Harry's rollout at Target
Jefferies analyst Kevin Grundy lowered his price target on Edgewell Personal Care (EPC) to $75 from $77 after Harry's shave club offerings launched nationwide at Target (TGT), saying his store checks revealed strong in-store execution for the roll-out. Grundy thinks soon-to-be acquired Dollar Shave Club will also to push into retail and expects other retailers, perhaps including Walmart (WMT), to follow Target's lead and offer shelf space to the "trendy" shave club brands. While saying this is also a risk to Procter & Gamble (PG), Grundy keeps his Buy rating and $98 price target on P&G shares, saying increased levels of investment in U.S. shaving are already factored in the company's guidance.
08/15/16
RILY
08/15/16
UPGRADE
Target $105
RILY
Buy
Procter & Gamble upgraded to Buy from Neutral at B. Riley
B. Riley analyst Linda Bolton Weiser upgraded Procter & Gamble to Buy saying she left a meeting with new CEO David Taylor with greater confidence in the company's improved organic sales growth. The analyst expects Procter & Gamble's multiple to continue expanding and she upped her price target for the shares to $105 from $74.
08/15/16
08/15/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Procter & Gamble (PG) upgraded to Buy from Neutral at B. Riley with analyst Linda Bolton Weiser saying she left a meeting with new Chief Executive Officer David Taylor with greater confidence in the company's improved organic sales growth. 2. Valeant (VRX) upgraded to Neutral from Underperform at Mizuho. 3. AAC Holdings (AAC) upgraded to Strong Buy from Outperform at Raymond James with analyst John Ransom ting favorable valuation, still high short interest, and good visibility on 2017 EBITDA, which is $8M above Street estimates. 4. American Eagle (AEO) upgraded to Buy from Hold at Deutsche Bank with analyst Tiffany Kanaga saying denim strength should drive upside to estimates in the second quarter while easier compares should keep the momentum going in the second half of 2016. 5. Bright Horizons (BFAM) upgraded to Overweight from Neutral at JPMorgan with analyst Andrew Steinerman saying the company is entering a period of above-average margin expansion. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
GPS Gap
$22.78

0.25 (1.11%)

10/07/16
DBAB
10/07/16
UPGRADE
Target $24
DBAB
Hold
Gap upgraded to Hold from Sell at Deutsche Bank
Deutsche Bank analyst Paul Trussell upgraded Gap to Hold saying the company's near- to medium-term setup is more favorable amid easing compares over the next few months and an improved apparel backdrop. Trussell raised his price target for the shares to $24 from $18.
10/07/16
UBSW
10/07/16
NO CHANGE
Target $16
UBSW
Sell
Gap distribution center fire impact not done being felt, says UBS
UBS analyst Michael Binetti noted Gap's distribution center fire in August had a significant impact on September sales and that the company estimates that the fire will be a 3 point drag to October same-store sales as well. Additionally, Binetti said Florida, Georgia and South Carolina account for 10% of the company's North America store count and that Gap will close some stores amid this weekend's hurricane, further impacting October sales. The company mentioned that merchant margins were higher than expected which should offset any negative earnings impact, however. The analyst is cautious of the company's ability to pull back on promotions to drive a comp inflection and reiterated his Sell rating and $16 price target on Gap shares.
10/07/16
JEFF
10/07/16
NO CHANGE
Target $32
JEFF
Buy
Jefferies sees 'sizable upside potential' in Gap shares
Jefferies analyst Randal Konik raises his price target for Gap shares to $32 from $30 following the retailer's September results. Trends are Old Navy are accelerating while a bottom setting in at The Gap, Konik tells investors in a research note. The analyst sees an "asymmetric risk/reward" for shares with downside "fairly limited" and "sizable upside potential." He sees easy comparisons as a near-term catalyst and keeps a Buy rating on the shares.
08/19/16
MSCO
08/19/16
NO CHANGE
Target $21
MSCO
Underweight
Gap valuation stretched adn upside limited, says Morgan Stanley
Morgan Stanley analyst Kimberly Greenberger said Gap's valuation appears stretched and upside is limited. The analyst said even the most bullish expectations for $2.25-$2.30 in 2017 implies zero earnings growth since 2012, with less scope for cuts in marketing expense, wage inflation, and other SG&A inflation. Greenberger has an Underweight rating on Gap and a $21 price target on shares.
NVAX Novavax
$1.88

-0.13 (-6.47%)

09/16/16
WEDB
09/16/16
DOWNGRADE
Target $2
WEDB
Neutral
Novavax downgraded to Neutral from Outperform at Wedbush
Wedbush analyst Heather Behanna downgraded Novavax to Neutral and lowered its price target to $2 from $14 after the company's Phase III trial of RSV vaccine failed. This is the fourth downgrade of Novavax today.
09/16/16
09/16/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. 21st Century Fox (FOX, FOXA) downgraded to Market Perform from Outperform at Bernstein with analyst Jason Park citing a reduction in his estimates for the company's Star India business. 2. Wells Fargo (WFC) downgraded to Underweight from Neutral at Atlantic Equities. 3. Citi (C) downgraded to Neutral from Buy at Goldman with analyst Richard Ramsden saying Citi's expected earnings inflection has failed to materialize and ROEs are at 7.7%, well below management's 10% target. 4. McCormick (MKC) downgraded to Market Perform from Outperform at Bernstein with analyst Alexia Howard citing valuation. 5. Novavax (NVAX) downgraded to Neutral from Overweight at Piper Jaffray, to Neutral from Overweight at JPMorgan, to Neutral from Buy at Ladenburg, to Neutral from Outperform at Wedbush, and to Neutral from Buy at Citi. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/16/16
SBSH
09/16/16
DOWNGRADE
Target $1.5
SBSH
Neutral
Novavax downgraded to Neutral from Buy at Citi
Citi analyst Joel Beatty downgraded Novavax to Neutral after the company's RSV vaccine for older adults failed in Phase 3. The analyst does not expect results from the one remaining clinical trial until 2019. He cut his price target for the shares to $1.50 from $12. Four other firms downgraded Novavax this morning.
09/16/16
LTCO
09/16/16
DOWNGRADE
LTCO
Neutral
Novavax downgraded to Neutral from Buy at Ladenburg
Ladenburg Thalmann analyst Kevin DeGeeter downgraded Novavax to Neutral without a price target after the company's Phase III trial for the RSV F nanoparticle vaccine failed. Shares were also downgraded this morning at Piper Jaffray and JPMorgan.
FXE Euro Currency Trust
$108.48

-0.54 (-0.50%)

DB Deutsche Bank
$13.53

-0.06 (-0.44%)

09/29/16
COWN
09/29/16
NO CHANGE
COWN
DoJ will not destabilize Deutsche Bank, says Cowen
Cowen analyst Jaret Seiberg sees little practical or political upside for the Justice Department to press Deutsche Bank for a penalty that is so large it could destabilize the bank and create a new financial crisis. He expects the penalty for violations related to mortgage-backed securities to be structured below the speculated $14B that seems to have alarmed the market. Seiberg adds both sides have incentives to reach a deal quickly.
09/30/16
09/30/16
NO CHANGE

Correction: Deutsche Bank credit upgraded to Neutral at BofA/Merrill
BofA/Merrill upgraded Deutsche Bank's credit to Neutral, not the equity.
09/19/16
09/19/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. DSW (DSW) initiated with a Negative at Susquehanna. 2. Deutsche Bank (DB) initiated with an Underperform at Credit Suisse. 3. UBS (UBS) initiated with a Neutral at Credit Suisse. 4. Cerner (CERN) initiated with a Neutral at BofA/Merrill. 5. Callidus Software (CALD) reinstated with an Outperform at Credit Suisse. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/19/16
FBCO
09/19/16
INITIATION
FBCO
Underperform
Deutsche Bank initiated with an Underperform at Credit Suisse
Credit Suisse analyst Jon Peace initiated Deutsche Bank with an Underperform saying the recent slow filing and capital shortfall will lower dividend expectations and keep shares under pressure.
UA Under Armour; also tag UAA
$37.82

-0.59 (-1.54%)

09/30/16
GUGG
09/30/16
INITIATION
Target $50
GUGG
Buy
Under Armour initiated with a Buy at Guggenheim
Guggenheim analyst Robert Drbul initiated Under Armour with a Buy and a $50 price target as he expects growth in the strong activewear/athletic category to continue and believes a premium multiple is warranted.
10/06/16
ROTH
10/06/16
NO CHANGE
Target $22.5
ROTH
Buy
Under Armour deal should drive MINDBODY platform exposure, says Roth Capital
Roth Capital analyst Darren Aftahi notes that Under Armour (UA) has announced integration of its popular MyFitnessPal application with MINDBODY's (MB) platform. The partnership will enable users to search, book and pay for fitness classes directly on the app, which the analyst believes should be beneficial to MINDBODY's subscribers and its business in general. While it is unclear whether the deal with Under Armour is exclusive, the analyst believes it could open the door for MINDBODY to strike similar deals with other large fitness apparel companies like Nike (NKE) and its Nike+ mobile application. He reiterates a Buy rating and $22.50 price target on MINDBODY's shares.
09/13/16
09/13/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Chevron (CVX) initiated with an Outperform at BMO Capital. 2. AB InBev (BUD) initiated with a Buy at Jefferies. 3. Altria Group (MO) and Reynolds American (RAI) were initiated with a Buy at Citi while the firm initiated Philip Morris (PM) with a Neutral. 4. Under Armour (UA) initiated with a Neutral at Nomura. 5. Xerox (XRX) initiated with a Buy at SunTrust. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/13/16
NOMU
09/13/16
INITIATION
Target $38
NOMU
Neutral
Under Armour initiated with a Neutral at Nomura
Nomura analyst Simeon Siegel initiated Under Armour with a Neutral and a $38 price target. The analyst is more cautious on the rate of growth of Under Armour's apparel business and said valuation is pricing in FY18 target beats, which will require flawless execution
EWG iShares MSCI Germany
$26.27

-0.12 (-0.45%)

EWZ MSCI Brazil Index
$35.14

0.22 (0.63%)

TODAY'S FREE FLY STORIES

NBR

Nabors Industries

$8.15

-0.08 (-0.97%)

10:10
01/17/18
01/17
10:10
01/17/18
10:10
Options
Nabors short-term calls active »

Nabors short-term calls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

10:10
01/17/18
01/17
10:10
01/17/18
10:10
General news
The 0.9% December U.S. industrial production surge »

The 0.9% December U.S.…

WILC

G. Willi-Food

$7.06

-0.17 (-2.35%)

10:10
01/17/18
01/17
10:10
01/17/18
10:10
Hot Stocks
G. Willi-Food reports indictments of former officers of Willi Food Investments »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DSW

DSW

$20.89

0.26 (1.26%)

10:06
01/17/18
01/17
10:06
01/17/18
10:06
Conference/Events
DSW management to meet with Jefferies »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

EXAS

Exact Sciences

$52.95

0.33 (0.63%)

10:04
01/17/18
01/17
10:04
01/17/18
10:04
Hot Stocks
Exact Sciences drops after release of abstract on possible Cologuard competitor »

Early weakness in shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 26

    Feb

VMW

VMware

$132.75

0.61 (0.46%)

10:02
01/17/18
01/17
10:02
01/17/18
10:02
Conference/Events
VMware management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 17

    Jan

  • 19

    Jan

GS

Goldman Sachs

$252.90

-5.33 (-2.06%)

10:01
01/17/18
01/17
10:01
01/17/18
10:01
Hot Stocks
Breaking Hot Stocks news story on Goldman Sachs »

Goldman Sachs CFO:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 18

    Jan

  • 31

    Jan

BAH

Booz Allen

$40.02

0.16 (0.40%)

10:01
01/17/18
01/17
10:01
01/17/18
10:01
Hot Stocks
Booz Allen awarded $165M 5-year contract to support USCYBERCOM »

the General Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

CMTL

Comtech

$21.40

-0.58 (-2.64%)

10:01
01/17/18
01/17
10:01
01/17/18
10:01
Hot Stocks
Comtech receives $19.1M follow-on contract »

Comtech announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:01
01/17/18
01/17
10:01
01/17/18
10:01
General news
Housing Market Index data reported »

January Housing Market…

ACLS

Axcelis

$30.30

1.15 (3.95%)

, AMAT

Applied Materials

$54.50

1.05 (1.96%)

10:00
01/17/18
01/17
10:00
01/17/18
10:00
Recommendations
Axcelis, Applied Materials analyst commentary  »

Axcelis lowered margin…

ACLS

Axcelis

$30.30

1.15 (3.95%)

AMAT

Applied Materials

$54.50

1.05 (1.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

FAST

Fastenal

$55.44

-0.15 (-0.27%)

10:00
01/17/18
01/17
10:00
01/17/18
10:00
Options
Fast action in Fastenal Feb 55s post earnings »

Fast action in Fastenal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

GS

Goldman Sachs

$253.61

-4.855 (-1.88%)

10:00
01/17/18
01/17
10:00
01/17/18
10:00
Hot Stocks
Goldman CFO: Trading facing 'low volatility, low activity' world »

CFO Marty Chavez said on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 18

    Jan

  • 31

    Jan

MVC

MVC Capital

$10.70

-0.02 (-0.19%)

09:59
01/17/18
01/17
09:59
01/17/18
09:59
Conference/Events
MVC Capital management to meet with JMP Securities »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

KEYW

KEYW

$6.46

0.09 (1.41%)

09:58
01/17/18
01/17
09:58
01/17/18
09:58
Conference/Events
KEYW management to meet with RBC Capital »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 21

    Feb

  • 22

    Feb

  • 14

    Jun

RIOT

Riot Blockchain

$18.28

-3.6 (-16.45%)

09:55
01/17/18
01/17
09:55
01/17/18
09:55
Options
Riot Blockchain Inc put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

LRCX

Lam Research

$190.39

1.88 (1.00%)

, MNST

Monster Beverage

$64.56

0.79 (1.24%)

09:55
01/17/18
01/17
09:55
01/17/18
09:55
Options
Early notable gainers among liquid option names on January 17th »

Notable gainers among…

LRCX

Lam Research

$190.39

1.88 (1.00%)

MNST

Monster Beverage

$64.56

0.79 (1.24%)

IBM

IBM

$167.92

4.07 (2.48%)

IFF

International Flavors

$155.52

2.98 (1.95%)

KLAC

KLA-Tencor

$107.66

0.37 (0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

  • 24

    Jan

  • 25

    Jan

DIS

Disney

$110.92

0.23 (0.21%)

09:55
01/17/18
01/17
09:55
01/17/18
09:55
Periodicals
Disney's 'Last Jedi' drops 92% in second weekend at Chinese box office, THR says »

Disney's "Star…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

  • 06

    Feb

AMZN

Amazon.com

$1,304.86

-0.34 (-0.03%)

, HD

Home Depot

$197.20

0.89 (0.45%)

09:55
01/17/18
01/17
09:55
01/17/18
09:55
Conference/Events
Wedbush retail/hardlines analyst holds an analyst/industry conference call »

Retail/Hardlines Analyst…

AMZN

Amazon.com

$1,304.86

-0.34 (-0.03%)

HD

Home Depot

$197.20

0.89 (0.45%)

LOW

Lowe's

$101.01

0.0371 (0.04%)

W

Wayfair

$84.68

0.18 (0.21%)

WSM

Williams-Sonoma

$54.02

0.17 (0.32%)

BBBY

Bed Bath & Beyond

$23.01

0.19 (0.83%)

TPX

Tempur Sealy

$63.72

-0.075 (-0.12%)

AZO

AutoZone

$780.00

-1.02 (-0.13%)

AAP

Advance Auto Parts

$114.60

0.703 (0.62%)

ORLY

O'Reilly Automotive

$257.89

-0.71 (-0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 17

    Jan

  • 18

    Jan

  • 18

    Jan

  • 08

    Feb

  • 18

    Feb

  • 20

    Feb

  • 22

    Feb

  • 18

    Mar

FB

Facebook

$178.39

-0.98 (-0.55%)

, TWTR

Twitter

$24.52

-0.14 (-0.57%)

09:55
01/17/18
01/17
09:55
01/17/18
09:55
Conference/Events
Senate Commerce, Science & Transportation Committee to hold a hearing »

The Committee holds a…

FB

Facebook

$178.39

-0.98 (-0.55%)

TWTR

Twitter

$24.52

-0.14 (-0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 17

    Jan

  • 18

    Jan

  • 23

    Jan

  • 31

    Jan

  • 07

    Feb

  • 08

    Feb

  • 28

    Feb

MRK

Merck

$62.32

0.25 (0.40%)

09:55
01/17/18
01/17
09:55
01/17/18
09:55
Conference/Events
Leerink pharmaceuticals analysts hold an analyst/industry conference call »

Analysts discuss whether…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 18

    Jan

  • 25

    Jan

  • 02

    Feb

  • 08

    Feb

  • 08

    Mar

  • 25

    Mar

  • 03

    Apr

  • 23

    Apr

  • 23

    Oct

OPGN

OpGen

$0.19

0.0143 (8.29%)

09:55
01/17/18
01/17
09:55
01/17/18
09:55
Conference/Events
OpGen to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

09:54
01/17/18
01/17
09:54
01/17/18
09:54
General news
Market opens with gains, but holding them will be the focus »

Stock futures were higher…

ACLS

Axcelis

$30.30

1.15 (3.95%)

09:53
01/17/18
01/17
09:53
01/17/18
09:53
Hot Stocks
Breaking Hot Stocks news story on Axcelis »

Axcelis drops 5% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

XLF

Financial Select Sector

$29.16

0.01 (0.03%)

, XLE

Energy Select Sector SPDR

$76.69

0.25 (0.33%)

09:52
01/17/18
01/17
09:52
01/17/18
09:52
Technical Analysis
Technical Take: S&P 500 moves moderately higher, sector breadth mixed »

The S&P 500 (SPX) was…

XLF

Financial Select Sector

$29.16

0.01 (0.03%)

XLE

Energy Select Sector SPDR

$76.69

0.25 (0.33%)

XLI

Industrial Select Sector SPDR

$79.59

0.14 (0.18%)

XLK

Technology Select Sector SPDR

$66.91

0.36 (0.54%)

XLP

Consumer Staples Sector SPDR

$57.23

0.32 (0.56%)

XLV

Health Care Select Sector SPDR

$87.53

0.28 (0.32%)

SPY

SPDR S&P 500 ETF Trust

$277.86

0.89 (0.32%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.